Upcoming Webinars

OEC webinars are submitted for both COPE and CE Broker accreditation. We work diligently to secure accreditation as quickly as possible—thank you for trusting Optometric Education Consultants with your continuing education!

Metabolic Drivers of Ocular Damage Insulin Resistance, GLP-1, Muscle Health, and Antioxidants in Disease and Prevention 

June 2, 2026 at 8:00 PM – 10:00 PM ET
Speaker: Greg Caldwell, OD

Course Description: This course explores how insulin resistance, GLP-1 physiology, muscle health, oxidative stress, and mitochondrial dysfunction drive ocular damage and accelerate disease progression. Attendees will learn how systemic metabolic dysfunction impacts the retina, optic nerve, cornea, and vasculature, and how preventive strategies—including metabolic screening, carotenoid assessment, muscle preservation, and nutritional optimization—can be integrated into optometric care.

COPE Accreditation: 104315-SD
TX/SC/MI: 20-1373272

C.O.R.N.E.A.  &  N.E.R.V.E.:  Two Novel Mnemonics to Preserve Vision in Two Parallel Diseases 

June 9, 2026 at 8:00 PM – 10:00 PM ET
Speaker: Austin Lifferth, OD

Course Description: This informal, interactive, and informative course dives into the intricate relationship between glaucoma and dry eye disease (DED), two prevalent and often coexisting ocular conditions. Through the innovative N.E.R.V.E.S. and C.O.R.N.E.A. mnemonics, participants will gain practical tools to enhance their diagnostic and treatment strategies. The course combines evidence-based medicine, clinical pearls, and case discussions to provide a comprehensive understanding of the pathophysiology, risk factors, and management approaches for these chronic, underdiagnosed conditions.

COPE Accreditation: 104165-GL 
TX/SC/MI: 20-1370453

**FREE 1HR CE **

Emerging Topical Therapies in Modern Eye Care

June 15, 2026 at 8:00 PM – 9:00 PM ET
Speaker: Greg Caldwell, OD, FAAO

Course Description: This course reviews recently FDA-approved topical ophthalmic pharmaceuticals relevant to contemporary optometric practice, with emphasis on indications, mechanisms of action, dosing considerations, and safety profiles. Newer agents used in the management of dry eye disease, presbyopia, and Demodex blepharitis are discussed, including emerging drug classes such as neuromodulators, anti-evaporative therapies, and novel antiparasitic agents, to support confident integration into clinical care.

COPE Accreditation: 104789-PH
TX/SC/MI: Pending

Join us following this free ce for a Symposium with Thea!

Symposium With Thea

June 15, 2026 at 9:00 PM – 9:30 PM ET
Speaker: TBA

A Fresh Look at Common Neuro-Ophthalmic Disorders 

July 7, 2026 at 8:00 PM – 10:00 PM ET
Speaker:Patricia Modica, OD, FAAO

Course Description: Coming Soon

COPE Accreditation: Pending 
TX/SC: Pending

The Unintended Consequences of High Myopia and Other Interesting Things

July 28, 2026 at 8:00 PM – 10:00 PM ET
Speaker: Mark Dunbar, OD, FAAO

Course Description: Coming Soon

COPE Accreditation: Pending 
TX/SC: Pending